Given that tau protein accumulation, not Aβ burden, is highly associated with AD-related clinical symptoms [13–15], understanding the independent influence of tau accumulation on cognitive function is important for early detection and developing interventions in AD. This evidence concerns the gene MAPT and Alzheimer disease.